Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer: The Phase - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Combination of Tiragolumab, Atezolizumab, and Chemotherapy in Treating Advanced Nonsquamous Non–Small Cell Lung Cancer: A Phase Study

  • By

  • Mark A. Socinski

  • Rolf Stahel

  • Dae Ho Lee

  • Federico Cappuzzo

  • Makoto Nishio

  • Christine M. Lovly

  • Ozgur Ozyilkan

  • Qingshan Li

  • Melissa Johnson

  • Edward B. Garon

  • Saadettin Kilickap

  • Flavio Augusto Ferreira da Silva

  • Jorge Alatorre-Alexander

  • Raymond Meng

  • Reena Amin

  • Christina Matheny

  • Sarah Troutman

  • Xiaohui Wen

  • Namrata S. Patil

  • Wei Zou

  • Delvys Rodriguez-Abreu

  • June 1, 2026

Share

Original Source(s)

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer: The Phase

  • by Mark A. Socinski, Rolf Stahel, Dae Ho Lee, Federico Cappuzzo, Makoto Nishio, Christine M. Lovly, Ozgur Ozyilkan, Qingshan Li, Melissa Johnson, Edward B. Garon, Saadettin Kilickap, Flavio Augusto Ferreira da Silva, Jorge Alatorre-Alexander, Raymond Meng, Reena Amin, Christina Matheny, Sarah Troutman, Xiaohui Wen, Namrata S. Patil, Wei Zou, Delvys Rodriguez-Abreu

  • June 1, 2026

Related Content

CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

  • September 7, 2026

  • 3 min
Toward Precision Cardio-Oncology in Breast Radiotherapy

Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma